[go: up one dir, main page]

RU2018127513A - METHOD FOR COUPLING PAIN SYNDROMES DUE TO MALIGNANT NORMAL FORMATIONS - Google Patents

METHOD FOR COUPLING PAIN SYNDROMES DUE TO MALIGNANT NORMAL FORMATIONS Download PDF

Info

Publication number
RU2018127513A
RU2018127513A RU2018127513A RU2018127513A RU2018127513A RU 2018127513 A RU2018127513 A RU 2018127513A RU 2018127513 A RU2018127513 A RU 2018127513A RU 2018127513 A RU2018127513 A RU 2018127513A RU 2018127513 A RU2018127513 A RU 2018127513A
Authority
RU
Russia
Prior art keywords
procedures
formations
coupling
pain syndromes
pain
Prior art date
Application number
RU2018127513A
Other languages
Russian (ru)
Other versions
RU2018127513A3 (en
RU2695350C2 (en
Inventor
Сергей Владимирович Потапов
Александр Владимирович Потапов
Галина Сергеевна Алексеева
Андрей Дмитриевич Каприн
Андрей Александрович Костин
Гузаль Рафаиловна Абузарова
Виктория Эдуардовна Хороненко
Станислав Владимирович КУЗНЕЦОВ
Светлана Евгеньевна Лапина
Регина Рашитовна Сарманаева
Original Assignee
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) filed Critical Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России)
Priority to RU2018127513A priority Critical patent/RU2695350C2/en
Publication of RU2018127513A publication Critical patent/RU2018127513A/en
Publication of RU2018127513A3 publication Critical patent/RU2018127513A3/ru
Application granted granted Critical
Publication of RU2695350C2 publication Critical patent/RU2695350C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Способ купирования болевых синдромов, обусловленных злокачественными новообразованиями, включающий использование ингаляционной терапии: смесь кислорода с инертным газом ксеноном, отличающийся тем, что ксенотерапию проводят в нормобарических условиях по закрытому дыхательному контуру с помощью газоанализатора газовой смесью ксенона и кислорода 50/50 об.%, количеством смеси от 4 до 6 л курсами от 5 до 10 дней по 1-2 процедуры, каждая от 05 до 15 мин в день с перерывами между процедурами 4-6 ч, причем количество процедур назначают до снижения интенсивности боли, оцениваемой суммарно за сутки по Нумерологической оценочной шкале (НОШ) боли.A method of stopping pain syndromes caused by malignant neoplasms, including the use of inhalation therapy: a mixture of oxygen with an inert gas xenon, characterized in that xenotherapy is carried out in normobaric conditions through a closed respiratory circuit using a gas analyzer with a gas mixture of xenon and oxygen 50/50 vol.%, The amount mixtures from 4 to 6 l in courses from 5 to 10 days for 1-2 procedures, each from 05 to 15 min per day with intervals between procedures of 4-6 hours, and the number of procedures is prescribed until the intensity decreases vnosti pain assessed cumulatively per day by numerological rating scale (Hom) pain.
RU2018127513A 2018-07-26 2018-07-26 Method of pain syndromes reduction caused by malignant growths RU2695350C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018127513A RU2695350C2 (en) 2018-07-26 2018-07-26 Method of pain syndromes reduction caused by malignant growths

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018127513A RU2695350C2 (en) 2018-07-26 2018-07-26 Method of pain syndromes reduction caused by malignant growths

Publications (3)

Publication Number Publication Date
RU2018127513A true RU2018127513A (en) 2018-10-01
RU2018127513A3 RU2018127513A3 (en) 2019-04-05
RU2695350C2 RU2695350C2 (en) 2019-07-23

Family

ID=63763143

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018127513A RU2695350C2 (en) 2018-07-26 2018-07-26 Method of pain syndromes reduction caused by malignant growths

Country Status (1)

Country Link
RU (1) RU2695350C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU201819U1 (en) * 2020-05-29 2021-01-14 Общество с ограниченной ответственностью "ИнертГаз Медикал" Universal gas dosing module

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2370269C2 (en) * 2006-04-17 2009-10-20 Михаил Владимирович Кутушов Method of malignant tumor treatment and gas composition (versions) for its realisation
WO2009047779A2 (en) * 2007-06-20 2009-04-16 Nikki Nikhilesh Singh Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form

Also Published As

Publication number Publication date
RU2018127513A3 (en) 2019-04-05
RU2695350C2 (en) 2019-07-23

Similar Documents

Publication Publication Date Title
AR082985A1 (en) PI3K-d INHIBITORS AND METHODS OF USE AND PREPARATION
CY1116315T1 (en) KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3
EA200702387A1 (en) IMIDAZOCHINOLINES AS LIPIDKINASE INHIBITORS
EA201270247A1 (en) METHODS OF APPLICATION OF C-METER-MODULATORS
Glaser Increase in locomotor activity following shielding of the parietal eye in night lizards
RU2018127513A (en) METHOD FOR COUPLING PAIN SYNDROMES DUE TO MALIGNANT NORMAL FORMATIONS
EA202091514A1 (en) METHODS FOR TREATMENT OF COLOR CANCER USING COMBINED THERAPY WITH NANOPARTICLES WITH mTOR INHIBITOR
EP3646938A4 (en) TREATMENT METHODS TO REDUCE CARBON DIOXIDE DISCHARGE QUANTITY FROM COMBUSTION GAS
TN2012000352A1 (en) Use of an adrenal hormone-modifying agent
MX2019006848A (en) Methods for treating inflammatory conditions of the lungs.
EP4548975A3 (en) Nitric oxide inhalation therapy for infants with bronchiolitis
TW200730532A (en) Camptothecin derivatives as chemoradiosensitizing agents
DE602007002915D1 (en) 2-BENZOYL-IMIDAZOPYRIDINE DERIVATIVES, METHOD OF MANUFACTURE AND ITS USE IN THERAPEUTICS
MX2019003710A (en) P2x3 and/or p2x2/3 compounds and methods.
EA202092558A1 (en) CRYSTALLINE FORM OF THE INHIBITOR c-MET, ITS SALT FORM AND METHOD OF THEIR PRODUCTION
RU2013109740A (en) METHOD FOR RARE-EARTH METAL EXTRACTION AND OBTAINING CONSTRUCTION GYPSUM FROM HEMOSHIDAL PHOSPHOGYPSUM
FI3058960T3 (en) Diagnostic agent for therapeutic effect on cancer
Masuda et al. Effects of various gaseous compounds and respiratory inhibitors on breaking dormancy of freesia corms
RU2010135259A (en) METHOD FOR IMPROVING HUMAN PHYSICAL OPERATION
RU2019104161A (en) Compositions for the treatment of pulmonary fibrosis
CHEN et al. Epidemiology and pathogenesis research progress of cancer-related fatigue
Otis et al. Effects of Adding Carbon Dioxide to Inspired Oxygen on Tolerance to High Altitudes.
RU2016141094A (en) METHOD FOR PRE-SEED TREATMENT OF SEEDS
RU2019134886A (en) METHOD FOR TREATING PAIN AT REHABILITATION OF ONCOLOGICAL PATIENTS AFTER SURGICAL INTERVENTIONS ON THE SPINE
RU2647258C1 (en) Method for protecting crops against drought